Insiders Cybin Inc.

Equities

CLXPF

CA23256X4075

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:00 2025-05-21 pm EDT			5-day change	1st Jan Change
7.020 ^USD	+0.14%		+10.03%	-20.41%

May. 08	Cybin Inc. Announces Additional U.S. Patent Supporting Its Cyb003 Therapy Program in Phase 3 Development for Major Depressive Disorder	CI
May. 08	Cybin Announces Additional U.S. Patent Supporting Its CYB003 Breakthrough Therapy Program In Phase 3 Development For Major Depressive Disorder	RE

Insiders

Cybin Inc. Announces Executive Appointments	24-10-01	CI
Cybin Inc. Announces the Realignment of the Composition of Governance and Nominating Committee, and Compensation Committee	24-08-13	CI
Cybin Inc. Appoints Atul R. Mahableshwarkar as Senior Vice President, Clinical Development	24-06-11	CI
Cybin Inc. Announces that George Tziras Joins the Board of Directors and Will Serve as Chief Business Officer	23-10-23	CI
Cybin Appoints Aaron Bartlone as Chief Operating Officer	23-06-30	MT
Cybin Inc. Announces Appointment of Aaron Bartlone as Chief Operating Officer, Effective July 1, 2023	23-06-29	CI
Cybin Announces Scientific Management Transition	23-06-05	CI
Cybin Inc. Appoints Leah Gibson to the Position of Vice President of Investor Relations	21-11-04	CI
Cybin Inc. Announces Executive Appointments	21-10-01	CI
Cybin Inc. Announces Election of Theresa Firestone as Director	21-08-16	CI
Cybin Appoints Thomas Laughren to the Advisory Board	21-06-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

BENEFIT NOW